Infectious disease expert and chief scientific adviser on the pandemic, Sotiris Tsiodras, discussed on Thursday the start of the clinical trials in Greece of an Israeli coronavirus treatment in two hospitals.
“We are participating in these new trials with great enthusiasm. The study utilizes a new method of transferring a new medicine, based on exosomes, nanoparticles that participate in intracellular activities,” said Tsiodras during a meeting in Athens with Israeli Professor of Medicine Nadir Arber who is responsible for the new drug against Covid-19 developed at the Medical Centre Ichilov in Tel Aviv.
“It is a very promising method according to the data from the clinical trials in Israel. We are moving forward by conducting Phase II trials here in Greece, in which we will evaluate parameters like safety, dosology, and efficacy,” he stated.
On his side, Arber said, “we should remain humble and modest – but we are really excited. In fact, I want to point out that I came here in person as I wanted to see the people first and then the facilities. We are talking about great doctors and people who have inspired my confidence.”
The treatment will be trialed in the Sotiria and Attikon hospitals in Athens.